Prosecution Insights
Last updated: April 19, 2026

Noveome Biotherapeutics, Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18036815 SECRETOME FRACTIONS AND USES THEREOF KNIGHT, TERESA E 1634 Non-Final OA May 12, 2023
17494690 MODULATING ISCHEMIC INJURY CLARKE, TRENT R 1651 Final Rejection Oct 05, 2021
17197580 Use of ST266 to Treat Severe Systemic Inflammation and Post-Acute COVID-19 Syndrome FORD, VANESSA L 1674 Final Rejection Mar 10, 2021
16690197 Novel methods for delivering therapeutics agents to the eye via the nasal passages MOSS, NATALIE M 1653 Non-Final OA Nov 21, 2019

Managing Noveome Biotherapeutics, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month